Literature DB >> 17960787

Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.

Tianhua Huang1, Karen Boucher, Anne M Summers.   

Abstract

OBJECTIVE: To investigate the association of Down syndrome screening results in successive pregnancies, and assess the impacts of including previous screening results in the current risk estimation on screening performance.
METHODS: The study was based on 56,951 women who had triple marker screening in two or more singleton pregnancies in the Ontario Maternal Serum Screening (MSS) program between October 1993 and September 2000. The problem of recurrent false positive results was examined by comparing screening results from different pregnancies in the same individuals. Between-pregnancy associations in the levels of serum markers were estimated using correlation analysis. A published method was used to adjust current risk estimation for previous screening results. The effect of this adjustment was assessed by comparing screening performances prior and subsequent to the adjustment.
RESULTS: The observed false positive rate (FPR) in subsequent pregnancies was 2.5 times higher than that expected (26.4% vs 10.7%) among women who screened positive in one previous pregnancy, and 3.9 times higher (47.4% vs 12.1%) among women who screened positive in two previous pregnancies. Adjusting for a previous screening result will significantly reduce the recurrent FPR without compromising detection.
CONCLUSION: Risk estimation for Down syndrome may be adjusted using the screening result from a previous pregnancy. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17960787     DOI: 10.1002/pd.1867

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  4 in total

Review 1.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 2.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 3.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

4.  Prenatal biochemical screening and long term risk of maternal cardiovascular disease: population based cohort study.

Authors:  Joel G Ray; Tianhua Huang; Wendy S Meschino; Eyal Cohen; Alison L Park
Journal:  BMJ       Date:  2018-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.